ctures medical instruments such as stents for coronaria, head arteria carotis, and bile passage and catheters. Its major product includes stents, guidewires and catheters which are customized to the needs of the users. Medical instruments are processed using advanced technologies such as Laser machining, carbon coating and biocompatibility, and surface functionalized polymer coating. Available technologies with Japan Stent include stent designing, fine laser processing, stent medical coating, metal surface polishing, and material surface functionalizing.
With its ISO certified stent design, the company has received grant money from the Ministry of Economy, Trade and Industry of Japan, Okayama Government, NEDO, National Institute of Biomedical Innovation, etc.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents. To join our Growth Partnership, please visit http://www.awards.frost.com.
Frost & Sullivan:
Ciara Jamie Connolly, Senior Events & Promotions Executive/ EMEA,
Frost & Sullivan, firstname.lastname@example.org, P: 0044 (0) 207.915.7868,
F: 0044 (0) 207.Page: 1 2 3 4 5 Related medicine technology :1
. Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics2
. Frost & Sullivan to Speak at 2010 International Consumer Electronics Digital Health Summit3
. Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award4
. Frost & Sullivan Product Quality Leadership Award in the European Ultrasound Market Conferred on SonoScape for S85
. Drug Candidates in Pipeline Offer Potential for Parkinsons Disease Therapeutics Market, Says Frost & Sullivan6
. Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays7
. Nonin Medical is Recognized by Frost & Sullivan for Remote Patient Monitoring Leadership8
. Frost & Sullivan Award Underlines Cipla Medpros Status as Company of the Year in the South African Generic Pharmaceutical Market9
. Frost & Sullivan Recognizes Fovia for its HDVR(R) Platform - A Disruptive Technology Breakthrough10
. Central and Eastern European Healthcare Markets Hold Strong Potential for Growth Despite the Economic Slowdown, Says Frost & Sullivan11
. Lifesciences IT Spending to Experience Mature Growth Rates Despite Economic Slowdown, Declares Frost & Sullivan